top of page
external-file_edited.png

USA Webinar I Talking about Essential Thrombocythemia (ET) and promising treatments

  • 36 minutes ago
  • 1 min read

On Friday, April 24th, 2026, there’s a new webinar focused on Essential Thrombocythemia (ET) and the future of treatment options.


This session will be led by Prof. Lucia Masarova, MD, Assistant Professor in the Department of Leukemia, Division of Cancer Medicine at MD Anderson Cancer Center (USA), and moderated by Peter Löffelhardt, Founder & CEO of GMPNSF.


ET is often perceived as a less severe MPN, which can sometimes be seen to have fewer research opportunities and less visibility. However, ongoing research is opening new possibilities, and this webinar will explore the emerging treatment strategies currently being developed in the United States.

ET is often perceived as a less severe MPN, which can sometimes be seen to have fewer research opportunities and less visibility. However, ongoing research is opening new possibilities, and this webinar will explore the emerging treatment strategies currently being developed in the United States.


This session offers an opportunity to better understand how clinical research is evolving and what it may represent for people living with ET.



This is what the Global MPN community is about: connection, learning, and support across borders. 🌍


To continue offering webinars and patient-focused spaces worldwide, we rely on community support. Donate and help us keep bringing the world together for MPN patients and families.

bottom of page